NCT07297667
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07297667
Title GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries CAN


No variant requirements are available.